Angela Yu

480 total citations
6 papers, 366 citations indexed

About

Angela Yu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Angela Yu has authored 6 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Angela Yu's work include Histone Deacetylase Inhibitors Research (2 papers), Epigenetics and DNA Methylation (2 papers) and Cancer Treatment and Pharmacology (2 papers). Angela Yu is often cited by papers focused on Histone Deacetylase Inhibitors Research (2 papers), Epigenetics and DNA Methylation (2 papers) and Cancer Treatment and Pharmacology (2 papers). Angela Yu collaborates with scholars based in United States, Germany and Canada. Angela Yu's co-authors include Robert F. Place, Marc Shuman, Long-Cheng Li, Zhongxia Qi, Ji Wang, Jingwei Yu, Vera Huang, Victoria Portnoy, Zhejun Jia and Katherine B. Chiappinelli and has published in prestigious journals such as Nucleic Acids Research, Cancer Research and Scientific Reports.

In The Last Decade

Angela Yu

6 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angela Yu United States	6	286	197	71	42	18	6	366
Olì Maria Victoria Grober Italy	7	280 1.0×	140 0.7×	66 0.9×	21 0.5×	16 0.9×	8	390
Yangjun Wu China	11	430 1.5×	384 1.9×	46 0.6×	32 0.8×	42 2.3×	22	537
Xuetao Shi China	9	174 0.6×	147 0.7×	45 0.6×	19 0.5×	32 1.8×	13	292
Bruna Rodrigues Muys United States	11	455 1.6×	353 1.8×	61 0.9×	29 0.7×	25 1.4×	15	532
Lupin Jiang China	8	195 0.7×	83 0.4×	80 1.1×	33 0.8×	19 1.1×	12	352
Yue Han China	8	355 1.2×	327 1.7×	50 0.7×	21 0.5×	30 1.7×	16	454
Enilze M.S.F. Ribeiro Brazil	10	208 0.7×	141 0.7×	56 0.8×	37 0.9×	25 1.4×	22	303
Bianca Busch Germany	9	387 1.4×	278 1.4×	26 0.4×	29 0.7×	7 0.4×	9	439
Xinhong Wang China	11	246 0.9×	179 0.9×	38 0.5×	18 0.4×	37 2.1×	16	332

Countries citing papers authored by Angela Yu

Since Specialization

Citations

This map shows the geographic impact of Angela Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Yu more than expected).

Fields of papers citing papers by Angela Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Yu. The network helps show where Angela Yu may publish in the future.

Co-authorship network of co-authors of Angela Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Yu. A scholar is included among the top collaborators of Angela Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Yu. Angela Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Dobersch, Stephanie, Adrianne Wallace-Povirk, Jaeseung Kim, et al.. (2023). Sirtuin 6 is required for the integrated stress response and resistance to inhibition of transcriptional cyclin-dependent kinases. Science Translational Medicine. 15(694). eabn9674–eabn9674. 5 indexed citations

2.

McDonald, James I., Elisa Arthofer, Melissa Hadley, et al.. (2021). Epigenetic Therapies in Ovarian Cancer Alter Repetitive Element Expression in a TP53 -Dependent Manner. Cancer Research. 81(20). 5176–5189. 23 indexed citations

3.

Moufarrij, Sara, Aneil Srivastava, Stephanie Gomez, et al.. (2020). Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer. Scientific Reports. 10(1). 3470–3470. 73 indexed citations

4.

Walko, Christine M., Austin J. Combest, Ivan Spasojević, et al.. (2012). The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients. Cancer Chemotherapy and Pharmacology. 69(5). 1189–1196. 17 indexed citations

5.

Huang, Vera, Robert F. Place, Victoria Portnoy, et al.. (2011). Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Research. 40(4). 1695–1707. 236 indexed citations

6.

Zamboni, William C., Austin J. Combest, Julie A. DeLoia, et al.. (2011). Pharmacologic and phenotypic study of docetaxel in patients with ovarian or primary peritoneal cancer. Cancer Chemotherapy and Pharmacology. 68(5). 1255–1262. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact